Microbiomes interconnect on a planetary-scale, new study finds
In the largest study of its kind, EMBL scientists reveal that certain microbes can thrive across different ecosystems, contributing to the global spread of antimicrobial resistance.
Edit
Meet the new Speaker of the Nordic EMBL Partnership for Molecular Medicine
The Nordic EMBL Partnership for Molecular Medicine has appointed Janna Saarela as its new Speaker. Saarela is the Director of the Norwegian Centre for Molecular Biosciences and Medicine (NCMBM) and su…
Edit
LimbLab: a tool to visualise development in 3D
Researchers at EMBL Barcelona have developed an open-source tool that makes working with complicated volumetric imaging data easier.
Edit
Archaea, the ultimate survivor
Possibly the least researched microorganism domain, archaea seem to survive anywhere. Yet it is extraordinarily challenging to study and unlock their secrets of adaptability. EMBL researchers hope to …
Edit
Welcome: Florian Wollweber
The new EMBL Grenoble group leader will explore the origin of eukaryotes and their complex cellular organisation by studying Asgard archaea and other non-model microorganisms.
Edit
Message from the EMBL Council Chair
Virginijus Siksnys on EMBL’s interim leadership arrangements
Edit
Remembering Peer Bork (1963—2026)
The EMBL community is deeply saddened by the passing of Interim Director General Professor Peer Bork, a pioneering scientist who left an indelible imprint on life science research in Europe and beyond…
Edit
In remembrance of Peer Bork
bork EMBL and its community are deeply saddened by the death of Peer Bork, the organisation’s Interim Director General.
Edit
TREC partner snapshot: European Marine Biological Resource Centre (EMBRC)
As a core partner of the TREC expedition, EMBRC provides access to a vast network of marine stations across Europe, allowing researchers to study coastal and marine ecosystems at scale.
Edit
EMBL alumni in action: Norbert Kraut
Alumnus Norbert Kraut reflects on how his time at EMBL led to his successes in addressing hard-to-treat lung cancer.
Edit